FDA Webview
X

Free FDA Notices

Mevacor Not Withdrawn for S&E

01/21/2016

Federal Register Notice: FDA has determined that Mevacor (lovastatin) tablets, 20 mg and 40 mg, were not withdrawn from sale for reasons of safety or effectiveness. This will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. To view this notice, click here.

LATEST NEWS